OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth
Molecular Cell · 2025-02 · 85 (4) · 843-856.e6
DOI: 10.1016/j.molcel.2024.12.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-02. Verfasst von Dong Guo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Canc…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Coenzyme A-Transferases, Ketone Bodies. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministry of Public Security of the People's Republic of China, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Ketone bodies generated in hepatocytes in the adult liver are used for nonhepatic tissues as an energy source. However, ketolysis is reactivated in hepatocellular carcinoma (HCC) cells with largely unelucidated mechanisms. Here, we demonstrate that 3-oxoacid CoA-transferase 1 (OXCT1), a rate-limiting enzyme in ketolysis, interacts with SUCLA2 upon IGF1 stimulation in HCC cells. This interaction results from ERK2-mediated SUCLA2 S124 phosphorylation and subsequent PIN1-mediated cis-trans isomerization of SUCLA2. OXCT1-associated SUCLA2 generates succinyl-CoA, which not only serves as a substrate for OXCT1 but also directly succinylates OXCT1 at K421 and activates OXCT1. SUCLA2-regulated OXCT1 activation substantially enhances ketolysis, HCC cell proliferation, and tumor growth in mice. Notably, treatment with acetohydroxamic acid, an OXCT1 inhibitor used clinically for urinary infection, inhibits liver tumor growth in mice and significantly enhances lenvatinib therapy. Our findings highlight the role of SUCLA2-coupled regulation of OXCT1 succinylation in ketolysis and unveil an unprecedented strategy for treating HCC by interrupting ketolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang Universit…
- Department of Health Management Center & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 611731, China. Electronic address…
- Cancer Center, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China.
- Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang 310018, China.
- Department of Oncology, the Affiliated Hospital of Qingdao University, Qingdao Cancer Institute, Qingdao, Shandong 266071, China.
Förderung
- Ministry of Public Security of the People's Republic of China
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Guo, D., Yu, Q., Tong, Y., Qian, X., Meng, Y., Ye, F., Jiang, X., Wu, L., Yang, Q., Li, S., Li, M., Wu, Q., Xiao, L., He, X., Zhu, R., Liu, G., Nie, D., Luo, S., Ma, L., …, & Lu, Z. (2025). OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. Molecular Cell, 85(4), 843-856.e6. https://doi.org/10.1016/j.molcel.2024.12.025
Vancouver
Guo D, Yu Q, Tong Y, Qian X, Meng Y, Ye F, et al. OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. Molecular Cell. 2025;85(4):843-856.e6. doi:10.1016/j.molcel.2024.12.025
BibTeX
@article{Guo2025,
author = {Guo, Dong and Yu, Qiujing and Tong, Yingying and Qian, Xu and Meng, Ying and Ye, Fei and Jiang, Xiaoming and Wu, Lihui and Yang, Qingqing and Li, Suyao and Li, Min and Wu, Qingang and Xiao, Liwei and He, Xuxiao and Zhu, Rongxuan and Liu, Guijun and Nie, Dou and Luo, Shudi and Ma, Leina and Jin, Ren-An and Liu, Zhihua and Liang, Xiao and Yan, Dong and Lu, Zhimin},
title = {OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {4},
pages = {843--856.e6},
doi = {10.1016/j.molcel.2024.12.025}
}
EUVIMED